Medicare Enrolled

Dr. Scott McWilliams, MD

Neurology · Rocky Point, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
170 ROUTE 25A, Rocky Point, NY 11778
6313314377
In practice since 2005 (20 years)
NPI: 1013918812 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McWilliams from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McWilliams? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McWilliams

Dr. Scott McWilliams is a neurology specialist in Rocky Point, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. McWilliams performed 17,837 Medicare services across 1,197 unique beneficiaries.

Between the years covered by Open Payments, Dr. McWilliams received a total of $10,613 from 70 pharmaceutical and/or device companies across 568 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McWilliams is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in NY $10,613 industry payments

Medicare Practice Summary

Medicare Utilization ↗
17,837
Medicare services
Top 5% in NY for neurology
1,197
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~892 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
16,200 $5 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
553 $77 $270
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
357 $49 $155
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
167 $149 $600
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
125 $115 $390
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
82 $77 $250
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
61 $161 $880
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
57 $92 $455
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
44 $110 $331
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
41 $93 $390
Chemical nerve block injection, 1-4 muscles
An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated.
36 $152 $805
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
33 $159 $525
Electrocardiogram, 1-3 leads with physician review
A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician.
23 $12 $50
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
23 $367 $1,350
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
19 $195 $825
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
16 $166 $695
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,613
Total received (2018-2024)
Avg $1,516/year across 7 years
Top 24% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
568
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,560 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$53 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,109
2023
$1,607
2022
$1,964
2021
$1,687
2020
$1,404
2019
$885
2018
$957

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$463
ARGENX US, INC.
$238
Novartis Pharmaceuticals Corporation
$189
Amneal Pharmaceuticals LLC
$181
Lundbeck LLC
$166
Lilly USA, LLC
$100
SCILEX PHARMACEUTICALS INC.
$82
ACADIA Pharmaceuticals Inc
$77
MDD US Operations, LLC
$62
Eisai Inc.
$53
Kyowa Kirin, Inc.
$48
EMD Serono, Inc.
$45
Azurity Pharmaceuticals, Inc.
$45
UCB, Inc.
$45
Grifols USA, LLC
$40
JAZZ PHARMACEUTICALS INC.
$37
PFIZER INC.
$34
Merz Pharmaceuticals, LLC
$28
CSL Behring
$24
Vanda Pharmaceuticals Inc.
$24
ITF Therapeutics LLC
$24
Alexion Pharmaceuticals, Inc.
$21
SK Life Science, Inc.
$19
Acorda Therapeutics, Inc
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Otsuka America Pharmaceutical, Inc.
$16
Celgene Corporation
$14
Top 3 companies account for 42.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,149
Biogen, Inc.
$859
Novartis Pharmaceuticals Corporation
$805
Allergan, Inc.
$792
Lundbeck LLC
$633
Sunovion Pharmaceuticals Inc.
$530
Amneal Pharmaceuticals LLC
$429
Amgen Inc.
$421
Lilly USA, LLC
$308
Acorda Therapeutics, Inc
$300
ARGENX US, INC.
$291
UCB, Inc.
$268
ACADIA Pharmaceuticals Inc
$250
UPSHER-SMITH LABORATORIES LLC
$232
Grifols USA, LLC
$210
Kyowa Kirin, Inc.
$201
PTC Therapeutics, Inc.
$173
Alexion Pharmaceuticals, Inc.
$164
AbbVie Inc.
$163
SK Life Science, Inc.
$162
EMD Serono, Inc.
$150
Almatica Pharma LLC
$101
Sumitomo Pharma America, Inc.
$100
Biohaven Pharmaceutical Holding Company Ltd.
$96
SCILEX PHARMACEUTICALS INC.
$82
Eisai Inc.
$81
MDD US Operations, LLC
$77
Adamas Pharmaceuticals, Inc.
$75
Azurity Pharmaceuticals, Inc.
$75
Otsuka America Pharmaceutical, Inc.
$69
JAZZ PHARMACEUTICALS INC.
$68
Allergan Inc.
$67
Biohaven Pharmaceuticals, Inc.
$56
Avion Pharmaceuticals
$54
Teva Pharmaceuticals USA, Inc.
$54
GE HEALTHCARE
$54
Akcea Therapeutics, Inc.
$54
Sarepta Therapeutics, Inc.
$54
Celgene Corporation
$52
Takeda Pharmaceuticals U.S.A., Inc.
$51
Supernus Pharmaceuticals, Inc.
$49
Neurelis, Inc.
$49
Impax Laboratories, Inc.
$48
MITSUBISHI TANABE PHARMA AMERICA, INC.
$44
CSL Behring
$43
Greenwich Biosciences, Inc.
$42
LivaNova USA, Inc.
$40
Philips Electronics North America Corporation
$38
PFIZER INC.
$34
Upsher-Smith Laboratories LLC
$33
Merz Pharmaceuticals, LLC
$28
Neurocrine Biosciences, Inc.
$27
GENZYME CORPORATION
$25
Vanda Pharmaceuticals Inc.
$24
ITF Therapeutics LLC
$24
ARBOR PHARMACEUTICALS, INC.
$23
Medtronic USA, Inc.
$20
Genentech USA, Inc.
$20
US WorldMeds, LLC
$19
Arbor Pharmaceuticals, Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$19
BANNER LIFE SCIENCES, LLC
$18
E.R. Squibb & Sons, L.L.C.
$18
HARMONY BIOSCIENCES LLC
$17
Avanir Pharmaceuticals, Inc.
$16
Octapharma USA, Inc.
$15
Bausch Health US, LLC
$14
MERZ NORTH AMERICA, INC.
$14
Promius Pharma LLC
$11
Collegium Pharmaceutical, Inc.
$10
Top 3 companies account for 26.5% of all-time payments
Associated products mentioned in payments ›
ACTIVA · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUSTEDO · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Briviact · CITALOPRAM · CREXONT · Dhivy · EMFLAZA · EMGALITY · EXONDYS 51 · Emflaza · Epidiolex · Exondys 51 · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LINZESS · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · PLEGRIDY · POMPE - DISEASE · PONVORY · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Respiratoriy Care Undiv · Rystiggo · SOLIRIS · SPINRAZA · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · Wellcentive Undiv · XEOMIN · XYWAV · Xembify · Xeomin · Xtampza ER · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Rocky Point?
Compare neurologists in the Rocky Point area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
206
Per 100K population
13.5
County median income
$128,329
Nearest hospital
JOHN T MATHER MEMORIAL HOSPITAL OF PORT JEFFERSON
6.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McWilliams is a mixed practice specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McWilliams experienced with botox injection, per unit?
Based on Medicare claims data, Dr. McWilliams performed 16,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McWilliams receive payments from pharmaceutical companies?
Yes. Dr. McWilliams received a total of $10,613 from 70 companies across 568 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McWilliams's costs compare to other neurologists in Rocky Point?
Dr. McWilliams's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McWilliams) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →